Spectra7 Microsystems Stock Forecast, Price & News

+0.09 (+6.43 %)
(As of 09/16/2021 02:48 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume5,989 shs
Average Volume38,892 shs
Market CapitalizationC$31.49 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SEV News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectra7 Microsystems and its competitors with MarketBeat's FREE daily newsletter.

About Spectra7 Microsystems

Spectra7 Microsystems Inc. operates as an analog semiconductor company in Canada and China. The company offers virtual reality (VR) products, including VR7050 to enable lightweight and ultra-thin active interconnects for gesture recognition and motion control backhaul; augmented reality (AR) -Connect, an integrated cable, connector, and embedded chipset product line for AR vision systems and wearable computing devices; and DreamWeVR to support high-bandwidth, near-zero latency VR head-mounted displays, and AR glasses. It also provides GaugeChanger; and USB 3.1 consumer interconnects for use in ultra-thin laptops, tablets, mobile devices, solid state disks, and wearable computing devices. Spectra7 Microsystems Inc. is headquartered in San Jose, California.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Spectra7 Microsystems (CVE:SEV) Frequently Asked Questions

What stocks does MarketBeat like better than Spectra7 Microsystems?

Wall Street analysts have given Spectra7 Microsystems a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Spectra7 Microsystems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Spectra7 Microsystems' next earnings date?

Spectra7 Microsystems is scheduled to release its next quarterly earnings announcement on Monday, November 29th 2021.
View our earnings forecast for Spectra7 Microsystems

How were Spectra7 Microsystems' earnings last quarter?

Spectra7 Microsystems Inc. (CVE:SEV) released its earnings results on Monday, August, 30th. The company reported ($0.10) EPS for the quarter. The business had revenue of $0.90 million for the quarter.
View Spectra7 Microsystems' earnings history

Who are Spectra7 Microsystems' key executives?

Spectra7 Microsystems' management team includes the following people:
  • Mr. Raouf Y. Halim, Pres, CEO & Director (Age 61, Pay $70.94k)
  • Mr. David Mier, Interim Chief Financial Officer
  • Mr. John Mitchell, Chief Marketing Officer
  • Mr. Gerald J. Hamilton, Sr. VP of Worldwide Sales (Age 67)

Who are some of Spectra7 Microsystems' key competitors?

What other stocks do shareholders of Spectra7 Microsystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spectra7 Microsystems investors own include Himax Technologies (HIMX), Gaming Nation (FAN), ProMIS Neurosciences (PMN), Exxon Mobil (XOM), BTCS (BTCS), MedMen Enterprises (MMNFF), Energous (WATT), Archer-Daniels-Midland (ADM), Blueprint Medicines (BPMC) and Church & Dwight (CHD).

What is Spectra7 Microsystems' stock symbol?

Spectra7 Microsystems trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SEV."

How do I buy shares of Spectra7 Microsystems?

Shares of SEV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Spectra7 Microsystems' stock price today?

One share of SEV stock can currently be purchased for approximately C$1.49.

How much money does Spectra7 Microsystems make?

Spectra7 Microsystems has a market capitalization of C$31.49 million and generates C$1.95 million in revenue each year.

What is Spectra7 Microsystems' official website?

The official website for Spectra7 Microsystems is

Where are Spectra7 Microsystems' headquarters?

Spectra7 Microsystems is headquartered at 110 Cochrane Dr Suite 200, MARKHAM, ON L3R 9S1, Canada.

How can I contact Spectra7 Microsystems?

Spectra7 Microsystems' mailing address is 110 Cochrane Dr Suite 200, MARKHAM, ON L3R 9S1, Canada. The company can be reached via phone at +1-905-4809109.

This page was last updated on 9/17/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.